![3-[[3,5-Bis(trifluoromethyl)phenyl]amino]-4-[[(1R,2R)-2-(1-piperidinyl)cyclohexyl]amino]-3-cyclobutene-1,2-dione, 98%,3-[[3,5-双(三氟甲基)苯基]氨基]-4-[(1R,2R)-2-(1-哌啶基)环己基]氨基]-3-环丁烯-1,2-二酮 , 98%](https://static.jkchemical.com/Structure/269/2698469.png)
3-[[3,5-双(三氟甲基)苯基]氨基]-4-[(1R,2R)-2-(1-哌啶基)环己基]氨基]-3-环丁烯-1,2-二酮 , 98%
3-[[3,5-Bis(trifluoromethyl)phenyl]amino]-4-[[(1R,2R)-2-(1-piperidinyl)cyclohexyl]amino]-3-cyclobutene-1,2-dione, 98%
分子式: C23H25F6N3O2
分子量: 489.50
纯度: 98%
| 包装 | 库存 | 价格 | |
|---|---|---|---|
暂无数据 | |||
推荐产品
基本信息
安全信息
化学和物理性质
产品描述
Technical Notes:
1. a-Hydrazination: Catalytic enantiosele ctive a-hydrazination of 1 ,3-dicarbonyl compounds with
azodicarboxylates was investigated in the presence of our newly developed hydrogen bonding catalyst.
2.Michael Addition: Asymmetric organocatalytic 1 ,4-additions provide access to a large number of
biologically relevant compounds.
References:
1.Org. Lett., 2010, 12, 2028-2031.
2.Org. Biomol. Chem., 2013. 11, 7 705-7711.
